Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity
Influenza poses a huge threat to global public health. Influenza vaccines are the most effective and cost-effective means to control influenza. Current influenza vaccines mainly induce neutralizing antibodies against highly variable globular head of hemagglutinin and lack cross-protection. Vaccine a...
Main Authors: | Zhuofan Li, Yiwen Zhao, Yibo Li, Xinyuan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/2/75 |
Similar Items
-
Development of MF-59 adjuvant using chitosan derivatives to influenza vaccine
by: Alireza Loghmani, et al.
Published: (2020-06-01) -
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
by: Adrian Egli, et al.
Published: (2014-05-01) -
MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico
by: Aurelio Cruz-Valdez, et al.
Published: (2018-02-01) -
Differential Regulation of DC Function, Adaptive Immunity, and MyD88 Dependence by Two Squalene Emulsion-Based Vaccine Adjuvants
by: Jayachandra Reddy Nakkala, et al.
Published: (2024-05-01) -
Formulation of hepatitis B vaccine in MF59 adjuvant and comparison of its immunization with Iran\'s commercial hepatitis B vaccine
by: Reyhaneh Mirzaei, et al.
Published: (2018-10-01)